Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets

The development of novel target therapies based on the use of RNA interference (RNAi) and antisense oligonucleotides (ASOs) is growing in an exponential way, challenging the chance for the treatment of the genetic diseases and cancer by hitting selectively targeted RNA in a sequence-dependent manner...

Descripción completa

Detalles Bibliográficos
Autores principales: Barresi, Vincenza, Musmeci, Camillo, Rinaldi, Alessandro, Condorelli, Daniele Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408055/
https://www.ncbi.nlm.nih.gov/pubmed/36012138
http://dx.doi.org/10.3390/ijms23168875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408055/
https://www.ncbi.nlm.nih.gov/pubmed/36012138
http://dx.doi.org/10.3390/ijms23168875

Ejemplares similares